Cargando…

Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells

OBJECTIVE: To study the biological characteristics of paclitaxel resistant endometrial carcinoma cells and its mechanism of drug resistance. METHOD: The paclitaxel resistant cell lines were established by high-dose paclitaxel (TAX) injection. The IC50 of paclitaxel was determined by CCK-8 assay in I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Jie, Li, Mengxiong, Deng, Liuzhi, Li, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098927/ https://www.ncbi.nlm.nih.gov/pubmed/30175145 http://dx.doi.org/10.1155/2018/8372085

Ejemplares similares

Comprehensive Analysis of the Control of Cancer Stem Cell Characteristics in Endometrial Cancer by Network Analysis
por: Liu, Yun, et al.
Publicado: (2021)

Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
por: Chandra, Vishal, et al.
Publicado: (2021)

Mammalian target of rapamycin inhibitor RAD001 sensitizes endometrial cancer cells to paclitaxel-induced apoptosis via the induction of autophagy
por: Wang, Huan, et al.
Publicado: (2016)

Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
por: Fujiwara, Kazuko, et al.
Publicado: (2011)

Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation
por: Zhou, Xiang, et al.
Publicado: (2015)

Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma
por: Shang, Chao, et al.
Publicado: (2019)

Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells
por: Qu, Yingchun, et al.
Publicado: (2017)

Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine
por: Castle, Brian T., et al.
Publicado: (2017)

Effects of Female Sex Hormones on Clusterin Expression and Paclitaxel Resistance in Endometrial Cancer Cell Lines
por: Won, Yong Sung, et al.
Publicado: (2011)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Comparative study on the biological characteristics of menstrual blood- and endometrium-derived endometrial cells
por: Zhao, Lei, et al.
Publicado: (2021)

Biological features, gene expression profile, and mechanisms of drug resistance of two‐ and three‐dimensional hepatocellular carcinoma cell cultures
por: Mei, Nan, et al.
Publicado: (2021)

Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin
por: Ueda, Yutaka, et al.
Publicado: (2010)

Ginsenoside Rg5 Sensitizes Paclitaxel—Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel—And Enhances the Anticancer Effect of Paclitaxel
por: Ramesh, Janani, et al.
Publicado: (2022)

POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma
por: Li, Yiran, et al.
Publicado: (2020)

Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel
por: Lang, Bin, et al.
Publicado: (2016)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
por: Affatato, Roberta, et al.
Publicado: (2022)

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents
por: Moxley, Katherine M., et al.
Publicado: (2010)

The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers
por: Goto, T, et al.
Publicado: (2008)

Mechanisms of Cisplatin in Combination with Repurposed Drugs against Human Endometrial Carcinoma Cells
por: Lin, Chi-Kang, et al.
Publicado: (2021)

Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line
por: Gu, Xi, et al.
Publicado: (2015)

Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells
por: Jiménez-Guerrero, Rocío, et al.
Publicado: (2018)

Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer
por: Li, Juan, et al.
Publicado: (2020)

Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms
por: Liu, Zhaohui, et al.
Publicado: (2014)

A Novel miR-98 Negatively Regulates the Resistance of Endometrial Cancer Cells to Paclitaxel by Suppressing ABCC10/MRP-7
por: Huang, Wei, et al.
Publicado: (2021)

Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2018)

Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
por: Zhao, Minzhi, et al.
Publicado: (2015)

Ipatasertib exhibits anti-tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo
por: O'donnell, Jillian, et al.
Publicado: (2023)

Biological effects of NODAL on endometrial cancer cells and its underlying mechanisms
por: Hong, Xiaoshan, et al.
Publicado: (2021)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer
por: Niu, Xiaxia, et al.
Publicado: (2022)

Oncogenic circular RNA circ_0007534 contributes to paclitaxel resistance in endometrial cancer by sponging miR-625 and promoting ZEB2 expression
por: Yi, Hanjie, et al.
Publicado: (2022)

ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer
por: Mori, Yutaro, et al.
Publicado: (2019)

Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings
por: Mangili, Giorgia, et al.
Publicado: (2006)

Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
por: Mori, N, et al.
Publicado: (2010)

Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells
por: Dinkic, Christine, et al.
Publicado: (2017)

Biological characteristics of human menstrual blood‐derived endometrial stem cells
por: Liu, Yanli, et al.
Publicado: (2017)

Study on clinical and biological characteristics of ameloblastic carcinoma
por: Niu, Zhixing, et al.
Publicado: (2020)

Paclitaxel-induced lung injury and its amelioration by parecoxib sodium
por: Liu, Wen-jie, et al.
Publicado: (2015)

An optical study of drug resistance detection in endometrial cancer cells by dynamic and quantitative phase imaging
por: Yao, Tian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_81cth0ut2512jr8hf78nr62mce